XSHG
688301
, Last price
Name
iRay Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
iRay Technology Company Limited specializes in the development, manufacturing, and global distribution of sophisticated flat panel X-ray detectors. These critical imaging components are utilized across a broad spectrum of applications, including medical diagnostics, dental imaging, oncology treatment planning, veterinary care, security screening, and industrial inspection, serving markets both within China and internationally. The company's diverse product portfolio features solutions such as wireless and tethered radiography panels, mammography detectors, dynamic/real-time imaging systems, and linear detector arrays, all supported by essential accompanying software. Founded in 2011, iRay Technology is headquartered in Shanghai, China.
Legal address
瑞庆路590号9幢2层202室
浦东新区, SH 201201
CN
浦东新区, SH 201201
CN
Headquarters
金海路1000号45栋
浦东新区, SH 200000
CN
浦东新区, SH 200000
CN
Address
Room 202, 2nd Floor, Building 9, No. 590 Ruiqing Road
Pudong Xinqu, SH 201201
CN
Pudong Xinqu, SH 201201
CN
Address
Building 45, No. 1000 Jinhai Road
Pudong Xinqu, SH 200000
CN
Pudong Xinqu, SH 200000
CN
Other language
iRay Technology Company Limited
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||